Apollo Hospitals Enterprise Limited has completed the acquisition of Apollo Gleneagles PET-CT Private Ltd (AGPCL). The transaction, finalized on October 3, 2025, involved acquiring 85,00,000 equity shares, representing 50% of AGPCL’s total equity. As a result, AGPCL is now a wholly-owned subsidiary of Apollo Hospitals, enhancing its healthcare services portfolio.
AGPCL Now Under Apollo Hospitals
Apollo Hospitals Enterprise Limited announced the successful completion of the acquisition of Apollo Gleneagles PET-CT Private Ltd (AGPCL) on October 3, 2025. With this transaction, AGPCL has officially become a wholly-owned subsidiary of Apollo Hospitals.
Transaction Details
The acquisition involved 85,00,000 equity shares of AGPCL with a face value of Rs. 10/- each. These shares, previously held by Parkway Healthcare (Mauritius) Pte Ltd, represented 50% of AGPCL’s total paid-up equity share capital. This move will allow for greater operational synergy and strategic alignment within the Apollo Hospitals group.
Source: BSE
